Kruszynski R - Search Results

1

Novel endomorphin-2 analogs with mu-opioid receptor antagonist activity.

Kruszynski R, Fichna J, do-Rego JC, Chung NN, Schiller PW, Kosson P, Costentin J, Janecka A. Kruszynski R, et al. J Pept Res. 2005 Sep;66(3):125-31. doi: 10.1111/j.1399-3011.2005.00282.x. J Pept Res. 2005. PMID: 16083439

2

Conformationally restricted peptides as tools in opioid receptor studies.

Janecka A, Kruszynski R. Janecka A, et al. Among authors: kruszynski r. Curr Med Chem. 2005;12(4):471-81. doi: 10.2174/0929867053362983. Curr Med Chem. 2005. PMID: 15720255 Review.

3

Enzymatic degradation studies of endomorphin-2 and its analogs containing N-methylated amino acids.

Janecka A, Kruszynski R, Fichna J, Kosson P, Janecki T. Janecka A, et al. Among authors: kruszynski r. Peptides. 2006 Jan;27(1):131-5. doi: 10.1016/j.peptides.2005.06.015. Epub 2005 Aug 8. Peptides. 2006. PMID: 16087275

4

Synthesis and biological activity of N-methylated analogs of endomorphin-2.

Kruszynski R, Fichna J, do-Rego JC, Janecki T, Kosson P, Pakulska W, Costentin J, Janecka A. Kruszynski R, et al. Bioorg Med Chem. 2005 Dec 15;13(24):6713-7. doi: 10.1016/j.bmc.2005.07.051. Epub 2005 Sep 6. Bioorg Med Chem. 2005. PMID: 16143536

5

Synthesis and antinociceptive activity of cyclic endomorphin-2 and morphiceptin analogs.

Janecka A, Fichna J, Kruszynski R, Sasaki Y, Ambo A, Costentin J, do-Rego JC. Janecka A, et al. Among authors: kruszynski r. Biochem Pharmacol. 2005 Dec 19;71(1-2):188-95. doi: 10.1016/j.bcp.2005.10.018. Epub 2005 Nov 10. Biochem Pharmacol. 2005. PMID: 16288997

6

Synthesis and activity of opioid peptidomimetics with β²- and β³-amino acids.

Gach-Janczak K, Piekielna-Ciesielska J, Adamska-Bartłomiejczyk A, Perlikowska R, Kruszyński R, Kluczyk A, Krzywik J, Sukiennik J, Cerlesi MC, Calo G, Wasilewski A, Zielińska M, Janecka A. Gach-Janczak K, et al. Among authors: kruszynski r. Peptides. 2017 Sep;95:116-123. doi: 10.1016/j.peptides.2017.07.015. Epub 2017 Aug 3. Peptides. 2017. PMID: 28782637

7

New derivatives of quinazoline and 1, 2-dihydroquinazoline n3-oxide with expected antitumor activity.

Mikiciuk-Olasik E, Baszczak-Swiatkiewiz K, Zurek E, Krajewska U, Rózalski M, Kruszyński R, Bartczak TJ. Mikiciuk-Olasik E, et al. Among authors: kruszynski r. Arch Pharm (Weinheim). 2004 May;337(5):239-46. doi: 10.1002/ardp.200100656. Arch Pharm (Weinheim). 2004. PMID: 15095417

8

Bis{mu-2-[(2,3-dichlorophenyl)amino]benzoato-kappaO}di-mu2-ethoxo-octamethyldi-mu3-oxo-tetratin(IV).

Kruszynski R, Bartczak TJ. Kruszynski R, et al. Acta Crystallogr C. 2005 Sep;61(Pt 9):m439-41. doi: 10.1107/S0108270105025989. Epub 2005 Aug 31. Acta Crystallogr C. 2005. PMID: 16143770

9

2,3-Dihydro-1,3-benzothiazol-2-iminium hydrogen oxydiacetate: a combined structural and theoretical study.

Trzesowska-Kruszynska A, Kruszynski R. Trzesowska-Kruszynska A, et al. Among authors: kruszynski r. Acta Crystallogr C. 2009 Jan;65(Pt 1):o19-23. doi: 10.1107/S0108270108038365. Epub 2008 Dec 13. Acta Crystallogr C. 2009. PMID: 19129603

10

Interplay between Polymorphism and Isostructurality in the 2-Fur- and 2-Thenaldehyde Semi- and Thiosemicarbazones.

Swiatkowski M, Trzesowska-Kruszynska A, Danielewicz A, Sobczak P, Kruszynski R. Swiatkowski M, et al. Among authors: kruszynski r. Molecules. 2020 Feb 23;25(4):993. doi: 10.3390/molecules25040993. Molecules. 2020. PMID: 32102204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61 results

Search Page

Filters